{
    "clinical_study": {
        "@rank": "102439", 
        "arm_group": {
            "arm_group_label": "Zeltiq Coolsculpting System", 
            "arm_group_type": "Experimental", 
            "description": "non-invasive device designed to cool subcutaneous fat without affecting adjacent or underlying structures."
        }, 
        "brief_summary": {
            "textblock": "Protocol is intended for the clinical evaluation of fat reduction in male breasts\n      (pseudogynecomastia) using the ZELTIQ Coolsculpting System.  The ZELTIQ Coolsculpting system\n      has received market clearance from the U.S.FDA for non-invasive fat layer reduction in the\n      flanks, and is commercially available.\n\n      Primary study endpoint is changes in the shape and reduction of the fat in the breast as\n      established by photographic imaging and ultrasound imaging of the treated area.\n\n      Secondary endpoints will provide supportive data to evaluate device performance (subject\n      satisfaction & fat reduction measured with ultrasound)."
        }, 
        "brief_title": "Targeted Fat Reduction of Pseudogynecomastia in the Male Breast Using the ZELTIQ Coolsculpting System", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Gynecomastia", 
        "condition_browse": {
            "mesh_term": "Gynecomastia"
        }, 
        "detailed_description": {
            "textblock": "not desired"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  INCLUDED:\n\n               1. Male subjects > 18 years of age and < 70 years of age.\n\n               2. Subject has clearly visible, palpable, excess fatty tissue in their breast area,\n                  and minimal fibrous tissue.\n\n               3. Subject has not had weight change exceeding 10 pounds in the preceding month.\n\n               4. Subject agrees to maintain their weight (i.e., within +/- 5 pounds) by not\n                  making any major changes in their diet or lifestyle during the course of the\n                  study.\n\n               5. Subject has read and signed a written informed consent form.\n\n                  Exclusion Criteria:\n\n                  EXCLUDED:\n\n               1. Subject has had a surgical procedure(s) in the area of intended treatment.\n\n               2. Subject has had an invasive fat reduction procedure (e.g., liposuction or\n                  mesotherapy) in the area of intended treatment.\n\n               3. Subject has had a non-invasive fat reduction and/or body contouring procedure in\n                  the area of intended treatment.\n\n               4. Subject needs to administer, or has a known history of, subcutaneous injections\n                  into the area of intended treatment (e.g., heparin, insulin) within the past\n                  month.\n\n               5. Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal\n                  cold hemoglobinuria.\n\n               6. Subject has a known history of Raynaud's disease, or any known condition with a\n                  response to cold exposure that limits blood flow to the skin.\n\n               7. Subject has a history of bleeding disorder or is taking any medication that in\n                  the investigator's opinion may increase the subject's risk of bruising.\n\n               8. Subject body mass index (BMI) exceeds 30.  BMI is defined as weight in pounds\n                  multiplied by 703 divided by the square of the height in inches.\n\n               9. Subject is taking or has taken diet pills or diet supplements within the past\n                  month.\n\n              10. Subject has any dermatological conditions, such as moderate to excessive skin\n                  laxity, or scars in the location of the treatment sites that may interfere with\n                  the treatment or evaluation.\n\n              11. Subject is unable or unwilling to comply with the study requirements.\n\n              12. Subject is currently enrolled in a clinical study of any other unapproved\n                  investigational drug or device.\n\n              13. Personal history of previous breast malignancy.\n\n              14. Any other condition or laboratory value that would, in the professional opinion\n                  of the investigator, potentially affect the subject's response or the integrity\n                  of the data or would pose an unacceptable risk to the subject.\n\n              15. Subject is taking any medication which could cause abnormal breast enlargement -\n                  including but not limited to: digoxin, furosemide, gonadotropins, clomiphene,\n                  phenytoin, and exogenous testosterone, ketoconazole, metronidazole, alkylating\n                  agents, cisplatin, spironolactone, cimetidine, flutamide, finasteride,\n                  etomidate, isonicotinic acid hydrazide, methyldopa, busulfan, tricyclic\n                  antidepressants, diazepam, penicillamine, omeprazole, phenothiazines, calcium\n                  channel blockers, angiotensin-converting enzyme (ACE) inhibitors.\n\n              16. Recent history (within the past 5 years)  of substance abuse (alcohol, marijuana\n                  or heroin).\n\n              17. Subject has no history of the following medical conditions: Klinefelter\n                  syndrome, Congenital anorchia, Testicular trauma, Testicular torsion, Viral\n                  orchitis, Kallmann syndrome , Pituitary tumors, Malignancies that increase the\n                  serum level of hCG (eg, large cell lung cancer, gastric carcinoma, renal cell\n                  carcinoma, hepatoma), Renal failure, Hyperthyroidism, Malnutrition, Androgen\n                  insensitivity syndrome, Five-alpha-reductase deficiency syndrome"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01791660", 
            "org_study_id": "DLVSC-ZA-001"
        }, 
        "intervention": {
            "arm_group_label": "Zeltiq Coolsculpting System", 
            "description": "Non-invasive device designed to cool subcutaneous fat without affecting adjacent or underlying structures.", 
            "intervention_name": "Zeltiq Coolsculpting System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 12, 2013", 
        "link": {
            "description": "related information", 
            "url": "http://www.carolinaskin.com"
        }, 
        "location": {
            "contact": {
                "email": "nurse@carolinaskin.com", 
                "last_name": "Cindy L Tucker, RN CCRP", 
                "phone": "704-375-6766", 
                "phone_ext": "3537"
            }, 
            "contact_backup": {
                "email": "razial@carolinaskin.com", 
                "last_name": "Razia Ludin, research assistant", 
                "phone": "704-375-6766", 
                "phone_ext": "3606"
            }, 
            "facility": {
                "address": {
                    "city": "Charlotte", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "28207"
                }, 
                "name": "Dermatology, Laser & Vein Specialists of the Carolinas"
            }, 
            "investigator": {
                "last_name": "Girish S Munavalli, MD MHS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Targeted Fat Reduction of Pseudogynecomastia in the Male Breast Using the ZELTIQ Coolsculpting System", 
        "overall_contact": {
            "email": "nurse@carolinaskin.com", 
            "last_name": "Cindy L Tucker, RN CCRP", 
            "phone": "704-375-6766", 
            "phone_ext": "3537"
        }, 
        "overall_contact_backup": {
            "email": "razial@carolinaskin.com", 
            "last_name": "Razia Ludin, Research assistant", 
            "phone": "704-375-6766", 
            "phone_ext": "3606"
        }, 
        "overall_official": {
            "affiliation": "Dermatology, Laser & Vein Specialists of the Carolinas", 
            "last_name": "Girish S Munavalli, MD MHS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Visual, photographic and ultrasound measured changes in the shape and reduction of the fat in the male breast.", 
            "measure": "reduction of the fat layer", 
            "safety_issue": "No", 
            "time_frame": "8 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01791660"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dermatology, Laser & Vein Specialists of the Carolinas", 
            "investigator_full_name": "Girish Munavalli, MD MHS", 
            "investigator_title": "MD,MHS", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Subject satisfaction measured by subject questionnaires.", 
            "measure": "visual reduction of the fat layer", 
            "safety_issue": "No", 
            "time_frame": "8 months"
        }, 
        "source": "Dermatology, Laser & Vein Specialists of the Carolinas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dermatology, Laser & Vein Specialists of the Carolinas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}